Prophylactic treatment for prevention of joint disease in hemophilia--cost versus benefit.
Roosendaal
Goris
G
Lafeber
Floris
F
D003362:Cost-Benefit Analysis; D005169:Factor VIII / Q000008:administration & dosage / Q000191:economics*; D006395:Hemarthrosis / Q000188:drug therapy / Q000517:prevention & control; D006467:Hemophilia A / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007592:Joint Diseases / Q000517:prevention & control*; D008297:Male
C078147:F8 protein, human; D005169:Factor VIII